![](/img/cover-not-exists.png)
411PPharmacological activity of CB-103: An oral pan-NOTCH inhibitor with a novel mode of action
Weber, D., Lehal, R., Frismantas, V., Bourquin, J-P., Bauer, M., Murone, M., Radtke, F.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx367.044
Date:
September, 2017
File:
PDF, 48 KB
english, 2017